SkinBioTherapeutics PLC (SBTX)

Industry Biotechnology

Sell

9.50p

Buy

10.00p

arrow-down-0.50p (-4.88%)

Prices updated at 31 Mar 2026, 16:29 BST

Prices minimum 15 mins delay

Prices in GBX

SkinBioTherapeutics PLC is a life science company. The company is engaged in the development of technology to protect, manage and restore skin utilising proteins found in human microbiota.

FTSE All-Share

-0.33%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

01 Apr 2026

20 Mar 2026

13 Mar 2026

09 Mar 2026

02 Mar 2026

20 Feb 2026

16 Feb 2026

13 Feb 2026

Key dates

	Forecast date
Annual general meeting	Dec 2026
Final results	Dec 2026
Annual report	Dec 2026
Half yearly results	Apr 2026

	Previous date
Annual general meeting	Dec 2025
Final results	Dec 2025
Annual report	Dec 2025
Half yearly results	Mar 2025

Company reports

30 Jun 2025

Annual Report

31 Dec 2019

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.